An Evaluation of Fructosamine Estimation in Screening for Gestational Diabetes Mellitus

P. Hughes,M. Agarwal,P. Newman,J. Morrison

DOI: https://doi.org/10.1111/j.1464-5491.1995.tb00574.x

IF: 3.5

1995-08-01

Diabetic Medicine

Abstract:Although persuasive arguments against routine screening for gestational diabetes mellitus (GDM) have been made, it is widely but not universally performed as a part of antenatal care. There is no international agreement on methods or criteria used for screening (or for diagnosis), and administered glucose‐load methods have significant practical difficulties in a busy antenatal clinic setting. However, recent evidence supports the concept of an increased level of importance being given to a diagnosis of GDM, with interest in the fetal and neonatal origins of adult disease being added to the short‐term obstetric and fetal concern during pregnancy. A second generation fructosamine test, corrected for total protein, has been evaluated as a practical alternative to glucose screening for GDM in a busy, multi‐ethnic antenatal clinic. This achieved a 79.4 % sensitivity and a 77.3 % specificity for a diagnosis of GDM confirmed by a glucose tolerance test using Carpenter's modified criteria. In view of the organizational simplicity of this sample/test requirement, a wider evaluation is suggested together with a re‐evaluation of clinical outcome criteria rather than blood glucose levels alone.